Laparoscopic retroperitoneal lymph node dissection after chemotherapy

Palese, Michael; Su, Li‐Ming; Kavoussi, Louis R.

doi:10.1016/s0090-4295(02)01670-9

Cited by 82 publications

(36 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[15][16][17] We believe that this low complication rate is due to the long experience with L-RPLND at our department and the limited number of surgeons involved.…”

Section: Results Of the Histological Evaluation Of Rplnd Specimensmentioning

confidence: 95%

Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

et al. 2008

View full text Add to dashboard Cite

show abstract

“…[15][16][17] We believe that this low complication rate is due to the long experience with L-RPLND at our department and the limited number of surgeons involved.…”

Section: Results Of the Histological Evaluation Of Rplnd Specimensmentioning

confidence: 95%

Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

et al. 2008

View full text Add to dashboard Cite

show abstract

“…Indeed, longer follow-up of the limited numbers of patients forgoing chemotherapy in the setting of positive lymph nodes needs to be conducted as well as future studies on the efficacy of L-RPLND alone for pathologic stage II disease. L-RPLND in postchemotherapy patients has an increased complication rate 19 ; therefore, patient selection is important. We performed postchemotherapy L-RPLND in four patients for 1.1 to 2.9 cm masses.…”

Section: L-rplnd For Low Stage Testicular Cancer 1487mentioning

confidence: 99%

Laparoscopic Retroperitoneal Lymph Node Dissection for Low-Stage Testicular Cancer

Skolarus

Bhayani

Chiang

et al. 2008

Journal of Endourology

View full text Add to dashboard Cite

Skolarus, T. A.; Bhayani, S. B.; Chang, H. C.; Brandes, S. B.; Kibel, A. S.; Landman, J.; and Figenshau, R. S., ,"Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer." Journal of Endourology.22,7. 1485Endourology.22,7. -1490Endourology.22,7. . (2008 Results: A total of 26 L-RPLND procedures were completed, 3 for paratesticular rhabdomyosarcoma. Mean operative time was 250 minutes (range 176-369 min); estimated blood loss was 145 mL (range 50-500 mL); lymph node count was 23.8 (range 8-48); and hospital stay was 1.5 days (range 1-3 d). Four patients underwent postchemotherapy L-RPLND for residual nodes (1.1-2.9 cm). There were no conversions to an open procedure, blood transfusions, or operative complications. Chemotherapy was instituted in five of six patients with pathologic stage II disease. Mean follow-up was 23.7 months without retroperitoneal disease recurrence. Conclusion: L-RPLND as a diagnostic and therapeutic tool provides the benefits of a minimally invasive approach to MMGCT. It is the procedure of choice at our institution for low-stage MMGCT and paratesticular rhabdomyosarcoma.

show abstract

“…Some studies showed a better preservation of cell-mediated immunity after laparoscopic surgery (44,45). However, these benefits are not applied to the peritoneal level, possibly related to the hypoxic environment due to pneumoperitoneum pressure and secondary effect of the carbon dioxide in the peritoneal macrophage response (35)(36)(37).…”

Section: Port-site Recurrencementioning

confidence: 99%

Laparoscopic surgery in urological oncology: brief overview

Colombo¹,

Haber²,

Rubinstein³

et al. 2006

Int. braz j urol.

View full text Add to dashboard Cite

The authors report the experience of a high-volume center with laparoscopic surgery in urological oncology, as well as a review of other relevant series. Laparoscopic outcomes in the treatment of adrenal, kidney, upper tract transitional cell carcinoma, bladder, prostate, and testicular malignancy are described in this review. Specific considerations as complications and port-site recurrence are also addressed. The authors concluded that the intermediate-term oncological data is encouraging and comparable to open surgery.

show abstract

Laparoscopic retroperitoneal lymph node dissection after chemotherapy

Cited by 82 publications

References 20 publications

Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Laparoscopic Retroperitoneal Lymph Node Dissection for Low-Stage Testicular Cancer

Laparoscopic surgery in urological oncology: brief overview

Contact Info

Product

Resources

About